Champions Oncology (STU:2I3) YoY EBITDA Growth : 171.84% (As of Oct. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Champions Oncology YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Champions Oncology's YoY EBITDA Growth for the quarter that ended in Oct. 2024 was 171.84%.

Champions Oncology's EBITDA per Share for the three months ended in Oct. 2024 was €0.07.

Champions Oncology YoY EBITDA Growth Historical Data

The historical data trend for Champions Oncology's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Champions Oncology YoY EBITDA Growth Chart

Champions Oncology Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

YoY EBITDA Growth

Get a 7-Day Free Trial

-207.27

250.85

64.04

-201.37

-135.14

Champions Oncology Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
YoY EBITDA Growth	Get a 7-Day Free Trial															-339.53	-10.08	156.58	182.98	171.84

Champions Oncology YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Champions Oncology's YoY EBITDA Growth for the fiscal year that ended in Apr. 2024 is calculated as:

	YoY EBITDA Growth (A: Apr. 2024 )
=	(EBITDA per Share (A: Apr. 2024 )	-	EBITDA per Share (A: Apr. 2023 ))	/	\| EBITDA per Share (A: Apr. 2023 ) \|
=	(-0.348	-	-0.148)	/	\| -0.148 \|
=	-135.14 %

Champions Oncology's YoY EBITDA Growth for the quarter that ended in Oct. 2024 is calculated as:

	YoY EBITDA Growth (Q: Oct. 2024 )
=	(EBITDA per Share (Q: Oct. 2024 )	-	EBITDA per Share (Q: Oct. 2023 ))	/	\| EBITDA per Share (Q: Oct. 2023 )) \|
=	(0.074	-	-0.103)	/	\| -0.103 \|
=	171.84 %

Champions Oncology YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Champions Oncology's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Champions Oncology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Champions Oncology Inc (STU:2I3) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

CSBR:USA

Address

One University Plaza, Suite 307, Hackensack, NJ, USA, 07601

Website

https://www.championsoncology.com

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Champions Oncology Headlines

No Headlines